Clinical Trial Update: Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion status of a Phase 1/2 trial evaluating ThermoDox with hyperthermia for breast cancer recurrence on the chest wall.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED